Vudalimab, CAS 2329669-72-7

Product Description: Vudalimab is a potent dual PD-1 and CTLA-4 inhibitor as a fully humanized bispecific monoclonal antibody. Vudalimab targets immune checkpoint receptors PD-1 and CTLA-4 and promotes tumor-selective T-cell activation[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Hedvat M, et, al. Dual Blockade of PD1 and CTLA4 with Bispecific Antibody XmAb20717 Promotes Human T Cell Activation and Proliferation.

CAS Number: 2329669-72-7

Molecular Weight: N/A

Compound Purity: 99.0

Research Area: Inflammation/Immunology

Solubility: 10 mM in DMSO

Target: CTLA-4;PD-1/PD-L1

• Artikelnummer: MEXHY-P99166-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99166-5
• Green Labware: Nein
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK